Your browser doesn't support javascript.
loading
Interest of integrins targeting in glioblastoma according to tumor heterogeneity and cancer stem cell paradigm: an update.
Malric, Laure; Monferran, Sylvie; Gilhodes, Julia; Boyrie, Sabrina; Dahan, Perrine; Skuli, Nicolas; Sesen, Julie; Filleron, Thomas; Kowalski-Chauvel, Aline; Cohen-Jonathan Moyal, Elizabeth; Toulas, Christine; Lemarié, Anthony.
Afiliação
  • Malric L; INSERM U1037, Center for Cancer Research of Toulouse, Toulouse, France.
  • Monferran S; INSERM U1037, Center for Cancer Research of Toulouse, Toulouse, France.
  • Gilhodes J; Faculty of Pharmaceutical Sciences, University of Toulouse III Paul Sabatier, Toulouse, France.
  • Boyrie S; Department of Biostatistics, IUCT-Oncopole, Toulouse, France.
  • Dahan P; INSERM U1037, Center for Cancer Research of Toulouse, Toulouse, France.
  • Skuli N; INSERM U1037, Center for Cancer Research of Toulouse, Toulouse, France.
  • Sesen J; INSERM U1037, Center for Cancer Research of Toulouse, Toulouse, France.
  • Filleron T; Department of Neurosurgery, Johns Hopkins University, Baltimore, Maryland, USA.
  • Kowalski-Chauvel A; INSERM U1037, Center for Cancer Research of Toulouse, Toulouse, France.
  • Cohen-Jonathan Moyal E; Department of Biostatistics, IUCT-Oncopole, Toulouse, France.
  • Toulas C; INSERM U1037, Center for Cancer Research of Toulouse, Toulouse, France.
  • Lemarié A; INSERM U1037, Center for Cancer Research of Toulouse, Toulouse, France.
Oncotarget ; 8(49): 86947-86968, 2017 Oct 17.
Article em En | MEDLINE | ID: mdl-29156849

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2017 Tipo de documento: Article